Boryung Pharmaceutical said Wednesday that it has launched Onbevzi, a biosimilar for Avastin (Ingredient: bevacizumab) developed by Samsung Bioepis in Korea. nnnn?? : KBR(http://www.koreabiomed.com)
Boryung Pharmaceutical on Tuesday disclosed clinical trial results that showed its hypertension drug Kanarb is effective in controlling the blood pressure of patients who have experienced a stroke.
Madrid, July 2nd, 2020.- PharmaMar (MSE:PHM) has announced today that its partner in South Korea, Boryung Pharmaceutical, has presented the results of in vitro studies of plitidepsin (Aplidin®) in SARS-CoV-2.
Medifron DBT, Dong-A ST, Medipost, Boryung Pharmaceutical, Ildong Pharmaceutical, Daewoong Pharmaceutical, SK Chemicals, and SK Biopharmaceuticals are working on treatments in neurology disorders such as Alzheimer’s disease.
After launching Karnab, South Korean drug major, Boryung Pharmaceuticals has joined hands again with Zuellig Pharma to sell its antihypertensive combination drugs Dukarb(ingredient: fimasartan/amlodipine) and Tuvero(ingredient: fimasartan/rosuvastatin) in Southeast Asian countries
Industry experts define as a blockbuster drug an extremely popular medicine that generates annual sales of at least 10 billion won ($8.6 million) for the company that produces it. No locally produced drug has posted annual sales of 50 billion won or more so far.